RayKnowChina Research Map
Shortlist

Other diseases

Coronary heart disease in Changchun

长春 冠心病

All diseases in Changchun

5 hospitals in Changchun

Order: papers led on coronary heart disease, 2021–2025, then A–Z. Research activity, not a rating of care.

Only hospitals listed for coronary heart disease: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Changchun may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.

  1. 20 papers led
  2. 15 papers led
    No open trial led
  3. 12 papers led
  4. 6 papers led
    No open trial led
  5. 1 paper led
    No open trial led

Coronary heart disease in every city Changchun on the disease page, with the national map

13

open trials on coronary heart disease with a hospital in Changchun

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Changchun as lead sponsor or study site. 5 of them are led by a hospital in Changchun. Check the registry for the current status. Whether someone can take part is decided by the study team.

Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.

  1. Recruiting
    A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
    Phase
    Phase 2
    Started
    2026-07
    Posted
    Registry
    NCT07521007

    Age 18 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Lanzhou, Shanghai, Suzhou, Tianjin, Wuhan, Xi'an

  2. Recruiting
    Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI
    Phase
    N/A
    Started
    2026-03
    Posted
    Registry
    NCT07846462

    Age 18 years to 85 years (registered criteria)

    Led by First Hospital of Jilin UniversityChangchun

  3. Recruiting
    Impact of Stepwise Pressure-Increasing NC Balloon Post-Dilation on Stent Expansion
    Phase
    N/A
    Started
    2026-01
    Posted
    Registry
    NCT07853261

    Age 18 years to Not stated (registered criteria)

    Led by First Hospital of Jilin UniversityChangchun

  4. Recruiting
    Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
    Phase
    Phase 4
    Started
    2025-11
    Posted
    Registry
    NCT07110415

    Age 40 years to 80 years (registered criteria)

    Lead sponsor is not a listed hospital; 41 listed hospitals as study sitesBeijing, Changchun, Chengdu, Chongqing, Dalian, Daqing, Guangzhou, Guiyang, Hangzhou, Harbin, Huzhou, Jinan, Lanzhou, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shantou, Shenyang, Shenzhen, Shijiazhuang, Tianjin, Xi'an, Yantai, Yinchuan, Zhangjiakou, Zhuhai

  5. Recruiting
    One-Month DAPT in CABG Patients
    Phase
    Phase 3
    Started
    2024-08
    Posted
    Registry
    NCT05997693

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Changchun, Shanghai

  6. Recruiting
    Single-cell Multi-omics Analyses of OCT-diagnosed Plaque Subtypes in Coronary Artery Disease (MOOP-CAD)
    Phase
    Not given
    Started
    2024-07
    Posted
    Registry
    NCT06489119

    Age 18 years to 85 years (registered criteria)

    Led by Second Affiliated Hospital of Harbin Medical University; 1 listed hospital as study siteChangchun, Harbin

  7. Recruiting
    Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
    Phase
    N/A
    Started
    2023-04
    Posted
    Registry
    NCT04124120

    Age 18 years to Not stated; women only (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Changchun, Shanghai

  8. Recruiting
    Randomization of Single vs Multiple Arterial Grafts
    Phase
    N/A
    Started
    2018-01
    Posted
    Registry
    NCT03217006

    Age 18 years to 70 years (registered criteria)

    Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Changchun, Shanghai

  9. Not yet recruiting
    Ticagrelor-Based Dual Antiplatelet Therapy Duration in CABG
    Phase
    N/A
    Started
    2026-05
    Posted
    Registry
    NCT06981390

    Age 18 years to 80 years (registered criteria)

    Led by Second Hospital of Jilin UniversityChangchun

  10. Not yet recruiting
    Total Arterial vs. Mixed Grafting in Left Coronary CABG
    Phase
    N/A
    Started
    2026-08
    Posted
    Registry
    NCT07057713

    Age 18 years to 80 years (registered criteria)

    Led by Second Hospital of Jilin UniversityChangchun

  11. Not yet recruiting
    Digital Remote Management for Care and Continuous Optimization Versus Usual Care in Patients With Coronary Heart Disease (DigiCare-CHD)
    Phase
    N/A
    Started
    2026-01
    Posted
    Registry
    NCT07332494

    Age 18 years to 75 years (registered criteria)

    Led by Beijing Anzhen Hospital; 3 listed hospitals as study sitesBeijing, Changchun, Dalian

  12. Not yet recruiting
    Perioperative Myocardial Injury in Patients Undergoing Coronary Artery Bypass Grafting: A Prospective Clinical Study
    Phase
    Not given
    Started
    2026-07
    Posted
    Registry
    NCT07650487

    Age 21 years to 80 years (registered criteria)

    Led by Second Hospital of Jilin UniversityChangchun

  13. Not yet recruiting
    Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
    Phase
    N/A
    Started
    2021-09
    Posted
    Registry
    NCT04995159

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 67 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chongqing, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Huai'an, Jinan, Kunming, Lanzhou, Luoyang, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shantou, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Xi'an, Xuzhou, Yantai, Yinchuan, Zhanjiang, Zhengzhou, Zhongshan, Zhuhai, Zibo

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

Disease research in Changchun

Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.

A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.

Papers led and open trials led by hospitals in Changchun, by disease
CancerBlood disordersOther diseases
HospitalNasopharyngeal carcinomaOesophageal squamous cell carcinomaHepatocellular carcinomaStomach cancerLung cancerPancreatic cancerBreast cancerGliomaHepatoblastomaRetinoblastomaChordomaOsteosarcomaGastrointestinal stromal tumourNeuroblastomaEwing sarcomaMultiple myelomaB-cell acute lymphoblastic leukaemiaAplastic anaemiaHaemophagocytic lymphohistiocytosisLymphomaBeta thalassaemiaHaemophilia AAtypical haemolytic uraemic syndromeThrombotic thrombocytopenic purpuraFanconi anaemiaNeuromyelitis optica spectrum disorderIgG4-related diseaseMyasthenia gravisMoyamoya diseaseWilson diseaseBiliary atresiaCoronary heart diseaseCongenital heart diseaseScoliosisAnti-NMDA receptor encephalitisTakayasu arteritisHepatic echinococcosisIdiopathic pulmonary fibrosisLymphangioleiomyomatosisAmyotrophic lateral sclerosisSpinal muscular atrophyFabry diseasePompe diseaseDuchenne muscular dystrophyBehçet diseaseAlport syndromeIgA nephropathyGaucher diseaseNiemann–Pick disease type COsteogenesis imperfectaPrimary biliary cholangitisPrimary sclerosing cholangitisCongenital diaphragmatic herniaHirschsprung diseaseInherited epidermolysis bullosaHereditary angioedemaFamilial adenomatous polyposisLeber hereditary optic neuropathyMajeed syndromeNGLY1 deficiencyISG15 deficiencyShortlist
Affiliated Hospital of Changchun University of Chinese Medicine长春中医药大学附属医院nonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenone6nonenonenone6nonenonenonenonenone3nonenonenonenonenonenonenonenone1nonenonenone1nonenonenonenonenonenonenonenonenonenone
China-Japan Union Hospital, Jilin University吉林大学白求恩第三医院(中日联谊医院)0none212231145122none00131104nonenonenone10nonenonenonenonenone3none22nonenone1542none0none1none10nonenonenone0none0nonenonenone11nonenonenonenonenonenonenonenonenone
First Hospital of Jilin University吉林大学第一医院35761 open417 open1121 open27772 open561 open13017072174 open024243 opennone021none11none142none202 open9252none1none201none03071 open1none0111nonenonenonenone0nonenonenonenone
Jilin Cancer Hospital吉林省肿瘤医院none04039none21nonenonenonenone0nonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Jilin Heart Hospitalnonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone
Jilin Province FAW General Hospital吉林省一汽总医院nonenonenonenonenonenonenonenonenonenonenone1nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Jilin Province People's Hospital吉林省人民医院nonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenonenone0none0nonenonenonenonenonenonenonenonenonenonenonenonenonenone
Second Hospital of Jilin University吉林大学第二医院0115173782010none1none111104nonenonenone6nonenonenonenonenonenone5nonenonenonenone123 open21none0none7none2nonenone1none107nonenonenone2nonenonenonenonenonenonenonenonenonenone

Column labels are short names. Choose one to open that disease in Changchun.

Other cities nearby

Straight-line distance from the city centre; counts are hospitals listed for coronary heart disease.

Counts are listed hospitals only, not every hospital in each city.

Where these numbers come from

Papers

English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions

Trials

ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Changchun on ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data